semaglutide didn't work will tirzepatide If does not work Tirzepatide vs. Semaglutide for Weight
Description
Current regulatory guidance maintains that GLP-1 RAs and GIP-GLP1RA are contraindicated in people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 (MEN2)
Current FDA status As of early 2026, no oral tirzepatide formulation has received FDA approval
Appetite is at its lowest
Dont know your BMI
2025, pp
a BMI 27 kg/m 2 to 30 kg/m 2
